We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




CT Matches MRI for Late-Window Stroke Evaluation

By MedImaging International staff writers
Posted on 18 Feb 2019
Print article
Image: As part of a new study, researchers found that for stroke patients treated 3-6 hours after onset with intravenous tPA, baseline MRI findings can identify subgroups that are likely to benefit from reperfusion therapies and can potentially identify subgroups that are unlikely to benefit or may be harmed (Photo courtesy of Medscape).
Image: As part of a new study, researchers found that for stroke patients treated 3-6 hours after onset with intravenous tPA, baseline MRI findings can identify subgroups that are likely to benefit from reperfusion therapies and can potentially identify subgroups that are unlikely to benefit or may be harmed (Photo courtesy of Medscape).
Stroke patients who underwent endovascular therapy had similar improvement following treatment, regardless of the perfusion imaging used to confirm their eligibility for surgical procedures, according to a new study.

Researchers Stanford University School of Medicine (CA, USA) and the University of Texas Health Science Center (UTHSCSA; Houston, USA) conducted a study to evaluate whether the imaging-based selection criteria--computerized tomography (CT) or magnetic resonance imaging (MRI)--used prior to endovascular therapy showed comparable outcome rates and treatment benefits. The trial comprised 38 stroke centers in the United States and 182 patients (median age 70 years, 51% women) with stroke treated within 6 to 16 hours from last known well.

All patients underwent either perfusion MRI or perfusion CT to confirm that they had sufficient amounts of salvageable tissue to make surgery viable. The results revealed that endovascular therapy benefit was uniform across patients of various ages, regardless of the symptom severity, time to treatment, location of occlusion, and type of perfusion imaging they underwent prior to endovascular therapy, indicating that either modality could be used for patient selection. The study was published on January 28, 2019, in JAMA Neurology.

"Endovascular therapy in the 6-16-hour time window in patients with evidence of salvageable tissue on brain perfusion imaging is beneficial in a broad patient population, including patients who have mild or severe symptoms, and who are selected by CT or MRI,” concluded lead author Maarten Lansberg, PhD, of Stanford University, and colleagues. “These results have health care implications indicating transferring potential candidates for late-window thrombectomy is associated with substantial clinical benefits, and should be encouraged.”

Rapid and effective revascularization is the mainstay of acute ischemic stroke treatment. Until recently, intravenous recombinant tissue-type plasminogen activator (r-tPA) was the only established therapeutic option. New studies have proven the benefit of endovascular treatment, and thrombectomy with stent retrievers is now recommended as the standard of care for acute ischemic strokes with a proximal large vessel occlusion in the anterior circulation.

Related Links:
Stanford University School of Medicine
University of Texas Health Science Center

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Wireless Handheld Ultrasound System
TE Air
New
Self-Driving Mobile C-arm
CIARTIC Move
New
Brachytherapy Planning System
Oncentra Brachy

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.